Tenaya Therapeutics, Inc. (TNYA)
0.6895
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 16:00
0.681
-0.01
(-1.23%)
After-Hours: 18:23
Tenaya Therapeutics Cash from Operations (TTM) : -52.32M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -52.32M |
| March 31, 2026 | -64.39M |
| December 31, 2025 | -68.26M |
| September 30, 2025 | -72.71M |
| June 30, 2025 | -76.95M |
| March 31, 2025 | -84.95M |
| December 31, 2024 | -90.50M |
| September 30, 2024 | -94.04M |
| June 30, 2024 | -97.84M |
| March 31, 2024 | -100.44M |
| December 31, 2023 | -102.07M |
| September 30, 2023 | -102.83M |
| Date | Value |
|---|---|
| June 30, 2023 | -106.75M |
| March 31, 2023 | -105.96M |
| December 31, 2022 | -104.42M |
| September 30, 2022 | -98.09M |
| June 30, 2022 | -87.19M |
| March 31, 2022 | -73.78M |
| December 31, 2021 | -60.81M |
| September 30, 2021 | -54.87M |
| June 30, 2021 | -47.74M |
| March 31, 2021 | -43.00M |
| December 31, 2020 | -35.45M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Intellia Therapeutics, Inc. | -346.64M |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Oncolytics Biotech, Inc. | -26.52M |
| Sangamo Therapeutics, Inc. | -90.34M |
| Sarepta Therapeutics, Inc. | 93.95M |